Anatomy and Neuroscience - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 10 of 14
  • Item
    Thumbnail Image
    Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies
    Jozwiak, J ; Kasperczyk, S ; Tomasik, T ; Osadnik, T ; Windak, A ; Studzinski, K ; Mastej, M ; Catapano, A ; Ray, KK ; Mikhailidis, D ; Toth, P ; Howard, G ; Lip, GYH ; Tomaszewski, M ; Charchar, FJ ; Sattar, N ; Williams, B ; MacDonald, TM ; Krzemien, P ; Dobrakowski, M ; Kasperczyk, A ; Nowak, D ; Skowron, L ; Zak, Z ; Lewek, J ; Banach, M (TERMEDIA PUBLISHING HOUSE LTD, 2020-05)
    INTRODUCTION: Cardiovascular disease (CVD) is a major cause of morbidity and mortality throughout the world. The LIPIDOGRAM2015 study was performed to estimate the prevalence of risk factors for atherosclerotic diseases as well as cardiovascular and related disorders in the primary care setting in Poland. The LIPIDOGEN2015 sub-study was designed to include a random cohort of patients in order to analyse parameters related to lipid metabolism, oxidative stress, inflammatory responses, autoimmune disorders, and gene variants that confer susceptibility to cardiometabolic and atherosclerotic diseases. MATERIAL AND METHODS: The recruitment was carried out by 438 primary care physicians in Poland. The expected number of patients recruited for the LIPIDOGRAM2015 study was 13,000-14,000 with 13-15% (1700-2000) also participating in the LIPIDOGEN2015 sub-study. Each patient had to complete a questionnaire concerning medical and family history, concomitant diseases, and pharmacotherapy. Anthropometric measurements were performed at the doctor's office. For the LIPIDOGEN2015 sub-study, saliva samples for DNA isolation and blood samples for measurement of glycated haemoglobin, oxidative stress parameters, autoantibody levels, and inflammatory cytokine profile and apolipoprotein profile were collected. Follow-up data will be obtained from the National Health Fund in Poland. RESULTS: The LIPIDOGRAM2015 and LIPIDOGEN2015 study cohort reflects the prevalence of cardiovascular risk factors and concomitant diseases, markers of oxidative stress, the presence of autoantibodies, inflammatory cytokine profile, and apolipoprotein profile, as well as genetic variants potentially conferring susceptibility to cardiometabolic and atherosclerotic diseases. CONCLUSIONS: This study presents the prevalence of different CV risk factors, with special emphasis on lipid disorders, and it assesses the relationship between inflammation, oxidative stress, and mutations in genes encoding proteins regulating lipid metabolism, as well as genes conferring susceptibility to cardiovascular, cardiometabolic, and related diseases.
  • Item
    No Preview Available
    Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney
    Eales, JM ; Jiang, X ; Xu, X ; Saluja, S ; Akbarov, A ; Cano-Gamez, E ; McNulty, MT ; Finan, C ; Guo, H ; Wystrychowski, W ; Szulinska, M ; Thomas, HB ; Pramanik, S ; Chopade, S ; Prestes, PR ; Wise, I ; Evangelou, E ; Salehi, M ; Shakanti, Y ; Ekholm, M ; Denniff, M ; Nazgiewicz, A ; Eichinger, F ; Godfrey, B ; Antczak, A ; Glyda, M ; Krol, R ; Eyre, S ; Brown, J ; Berzuini, C ; Bowes, J ; Caulfield, M ; Zukowska-Szczechowska, E ; Zywiec, J ; Bogdanski, P ; Kretzler, M ; Woolf, AS ; Talavera, D ; Keavney, B ; Maffia, P ; Guzik, TJ ; O'Keefe, RT ; Trynka, G ; Samani, NJ ; Hingorani, A ; Sampson, MG ; Morris, AP ; Charchar, FJ ; Tomaszewski, M (NATURE PORTFOLIO, 2021-05)
    The kidney is an organ of key relevance to blood pressure (BP) regulation, hypertension and antihypertensive treatment. However, genetically mediated renal mechanisms underlying susceptibility to hypertension remain poorly understood. We integrated genotype, gene expression, alternative splicing and DNA methylation profiles of up to 430 human kidneys to characterize the effects of BP index variants from genome-wide association studies (GWASs) on renal transcriptome and epigenome. We uncovered kidney targets for 479 (58.3%) BP-GWAS variants and paired 49 BP-GWAS kidney genes with 210 licensed drugs. Our colocalization and Mendelian randomization analyses identified 179 unique kidney genes with evidence of putatively causal effects on BP. Through Mendelian randomization, we also uncovered effects of BP on renal outcomes commonly affecting patients with hypertension. Collectively, our studies identified genetic variants, kidney genes, molecular mechanisms and biological pathways of key relevance to the genetic regulation of BP and inherited susceptibility to hypertension.
  • Item
    No Preview Available
    A Modified MTS Proliferation Assay for Suspended Cells to Avoid the Interference by Hydralazine and β-Mercaptoethanol
    Wang, Y ; Nguyen, DT ; Yang, G ; Anesi, J ; Kelly, J ; Chai, Z ; Ahmady, F ; Charchar, F ; Golledge, J (MARY ANN LIEBERT, INC, 2021-04-01)
    The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay is one of the most commonly used tests of cell proliferation. Hydralazine has been reported to interfere with the performance of the MTS assay when used on adherent cells. This study aimed to investigate whether hydralazine interferes with the performance of the MTS assay on suspended cells. THP-1 (a monocytic leukemia cell line) cells were cultured in the presence or absence of hydralazine (0, 10, 50, 100, and 500 μM) for 2 or 24 h. Cell numbers were analyzed using the MTS, trypan blue exclusion, or microscopic assays. A modified version of the standard MTS assay was established by centrifuging the cells and replacing the test medium with fresh culture medium immediately before the addition of the MTS reagent. Culture of THP-1 cells with hydralazine at concentrations of 50, 100, and 500 μM for 2 h increased absorbance (p < 0.001) in the standard MTS assay, whereas both the trypan blue exclusion assay and microscopy suggested no change in cell numbers. Culture of THP-1 cells with 100 and 500 μm hydralazine for 24 h increased absorbance (p < 0.05) in the standard MTS assay; however, trypan blue exclusion and microscopy suggested a decrease in cell numbers. In a cell-free system, hydralazine (100 and 500 μM) increased absorbance in a time- and concentration-dependent manner. The modified MTS assay produced results consistent with trypan blue exclusion and microscopy using THP-1 cells. In addition, the modified MTS assay produced reliable results when K562 and Jurkat cells were incubated with hydralazine or β-mercaptoethanol (βME). In conclusion, a simple modification of the standard MTS assay overcame the interference of hydralazine and βME when assessing suspended cells.
  • Item
    Thumbnail Image
    The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study
    Studzinski, K ; Tomasik, T ; Windak, A ; Banach, M ; Wojtowicz, E ; Mastej, M ; Tomaszewski, M ; Mikhailidis, DP ; Toth, PP ; Catapano, A ; Ray, KK ; Howard, G ; Lip, GYH ; Charchar, FJ ; Sattar, N ; Williams, B ; MacDonald, TM ; Penson, PE ; Jozwiak, JJ (MDPI, 2021-12)
    A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the years 2015 and 2016. A total of 438 primary care physicians enrolled 13,724 adult patients that sought medical care in primary health care practices. The prevalence of hypertension, diabetes mellitus, dyslipidaemia, and CVD were similar in urban and rural areas (49.5 vs. 49.4%; 13.7 vs. 13.1%; 84.2 vs. 85.2%; 14.4 vs. 14.2%, respectively). The prevalence of obesity (32.3 vs. 37.5%, p < 0.01) and excessive waist circumference (77.5 vs. 80.7%, p < 0.01), as well as abdominal obesity (43.2 vs. 46.4%, p < 0.01), were higher in rural areas in both genders. Mean levels of LDL-C (128 vs. 130 mg/dL, p = 0.04) and non-HDL-C (147 vs. 148 mg/dL, p = 0.03) were slightly higher in rural populations. Altogether, 14.3% of patients with CVD from urban areas and 11.3% from rural areas reached LDL <70 mg/dL (p = 0.04). There were no important differences in the prevalence of hypertension, diabetes, dyslipidaemia, and CVD, or in mean levels of blood pressure, cholesterol fractions, glucose, and HbA1c between Polish urban and rural primary care patient populations. A high proportion of patients in cities and an even-higher proportion in rural areas did not reach the recommended targets for blood pressure, LDL-C, and HbA1c, indicating the need for novel CVD-prevention programs.
  • Item
    Thumbnail Image
    Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study
    Labuz-Roszak, B ; Banach, M ; Skrzypek, M ; Windak, A ; Tomasik, T ; Mastej, M ; Tomaszewski, M ; Mikhailidis, DP ; Toth, PP ; Catapano, A ; Ray, KK ; Howard, G ; Lip, GYH ; Charchar, FJ ; Sattar, N ; Williams, B ; MacDonald, TM ; Penson, P ; Jozwiak, JJ (MDPI, 2021-10)
    BACKGROUND: The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. MATERIAL AND METHODS: From all patients in LIPIDOGRAM2015 Study (n = 13,724), 268 subjects had a history of ischaemic stroke and were included. RESULTS: 165 subjects (61.6%) used at least one preventive medication. Oral antiplatelet and anticoagulation agents were used by 116 (43.3%) and 70 (26.1%) patients, respectively. Only 157 (58.6%) participants used lipid-lowering drugs, and 205 (76.5%) were treated with antihypertensive drugs. Coronary heart disease (CHD) and dyslipidaemia were associated with antiplatelet treatment (p = 0.047 and p = 0.012, respectively). A history of atrial fibrillation, CHD, and previous myocardial infarction correlated with anticoagulant treatment (p = 0.001, p = 0.011, and p < 0.0001, respectively). Age, gender, time from stroke onset, place of residence, and level of education were not associated with antiplatelet or anticoagulant treatment. Only 31.7% of patients were engaged in regular physical activity, 62% used appropriate diet, and 13.6% were current smokers. CONCLUSIONS: In Poland drugs and lifestyle modification for secondary stroke prevention are not commonly adhered to. Educational programmes for physicians and patients should be developed to improve application of effective secondary prevention of stroke.
  • Item
    Thumbnail Image
    Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
    Matias-Garcia, PR ; Wilson, R ; Guo, Q ; Zaghlool, SB ; Eales, JM ; Xu, X ; Charchar, FJ ; Dormer, J ; Maalmi, H ; Schlosser, P ; Elhadad, MA ; Nano, J ; Sharma, S ; Peters, A ; Fornoni, A ; Mook-Kanamori, DO ; Winkelmann, J ; Danesh, J ; Di Angelantonio, E ; Ouwehand, WH ; Watkins, NA ; Roberts, DJ ; Petrera, A ; Graumann, J ; Koenig, W ; Hveem, K ; Jonasson, C ; Koettgen, A ; Butterworth, A ; Prunotto, M ; Hauck, S ; Herder, C ; Suhre, K ; Gieger, C ; Tomaszewski, M ; Teumer, A ; Waldenberger, M (AMER SOC NEPHROLOGY, 2021-07)
    BACKGROUND: Studies on the relationship between renal function and the human plasma proteome have identified several potential biomarkers. However, investigations have been conducted largely in European populations, and causality of the associations between plasma proteins and kidney function has never been addressed. METHODS: A cross-sectional study of 993 plasma proteins among 2882 participants in four studies of European and admixed ancestries (KORA, INTERVAL, HUNT, QMDiab) identified transethnic associations between eGFR/CKD and proteomic biomarkers. For the replicated associations, two-sample bidirectional Mendelian randomization (MR) was used to investigate potential causal relationships. Publicly available datasets and transcriptomic data from independent studies were used to examine the association between gene expression in kidney tissue and eGFR. RESULTS: In total, 57 plasma proteins were associated with eGFR, including one novel protein. Of these, 23 were additionally associated with CKD. The strongest inferred causal effect was the positive effect of eGFR on testican-2, in line with the known biological role of this protein and the expression of its protein-coding gene (SPOCK2) in renal tissue. We also observed suggestive evidence of an effect of melanoma inhibitory activity (MIA), carbonic anhydrase III, and cystatin-M on eGFR. CONCLUSIONS: In a discovery-replication setting, we identified 57 proteins transethnically associated with eGFR. The revealed causal relationships are an important stepping stone in establishing testican-2 as a clinically relevant physiological marker of kidney disease progression, and point to additional proteins warranting further investigation.
  • Item
    Thumbnail Image
    Establishment of sex difference in circulating uric acid is associated with higher testosterone and lower sex hormone-binding globulin in adolescent boys
    Wang, Y ; Charchar, FJ (NATURE PORTFOLIO, 2021-08-30)
    Men have higher circulating levels of uric acid than women. This sex difference is suspected to be a result of suppressive effects of estradiol on uric acid. If so, estradiol would be inversely associated with circulating uric acid. This study aimed to test this hypothesis. This cross-sectional study included 9472 participants (weighted sample size of 184,342,210) aged 12-80 years from the 2013 to 2016 US National Health and Nutrition Examination Survey. Associations of sex hormones with uric acid were analyzed using weighted least squares regression, adjusting for demographic characteristics, lifestyle risk factors, and comorbidities. Neither free nor bioavailable estradiol was inversely associated with circulating uric acid in adolescent boys or girls, or adult men or women, or perimenopausal women after full adjustment. The sex difference in uric acid was established during adolescence as a result of a dramatic increase in uric acid in adolescent boys. During adolescence, the increase in estradiol in girls over time was accompanied by a relatively unchanged level of uric acid. All three fractions of estradiol (free, bioavailable, and total) were positively associated with uric acid in adolescent boys and girls after full adjustment. In adolescent boys, all three fractions of testosterone were positively associated with serum uric acid, and sex hormone-binding globulin was inversely associated with uric acid after full adjustment. These results suggest that estradiol is not inversely associated with circulating uric acid in adolescents and the establishment of sex difference in circulating uric acid during adolescence is associated with higher testosterone and lower sex hormone-binding globulin in adolescent boys.
  • Item
    No Preview Available
    Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals
    Surendran, P ; Feofanova, E ; Lahrouchi, N ; Ntalla, I ; Karthikeyan, S ; Cook, J ; Chen, L ; Mifsud, B ; Yao, C ; Kraja, AT ; Cartwright, JH ; Hellwege, JN ; Giri, A ; Tragante, V ; Thorleifsson, G ; Liu, DJ ; Prins, BP ; Stewart, ID ; Cabrera, CP ; Eales, JM ; Akbarov, A ; Auer, PL ; Bielak, LF ; Bis, JC ; Braithwaite, VS ; Brody, JA ; Daw, EW ; Warren, HR ; Drenos, F ; Nielsen, SF ; Faul, JD ; Fauman, EB ; Fava, C ; Ferreira, T ; Foley, CN ; Franceschini, N ; Gao, H ; Giannakopoulou, O ; Giulianini, F ; Gudbjartsson, DF ; Guo, X ; Harris, SE ; Havulinna, AS ; Helgadottir, A ; Huffman, JE ; Hwang, S-J ; Kanoni, S ; Kontto, J ; Larson, MG ; Li-Gao, R ; Lindstrom, J ; Lotta, LA ; Lu, Y ; Luan, J ; Mahajan, A ; Malerba, G ; Masca, NGD ; Mei, H ; Menni, C ; Mook-Kanamori, DO ; Mosen-Ansorena, D ; Muller-Nurasyid, M ; Pare, G ; Paul, DS ; Perola, M ; Poveda, A ; Rauramaa, R ; Richard, M ; Richardson, TG ; Sepulveda, N ; Sim, X ; Smith, A ; Smith, JA ; Staley, JR ; Stanakova, A ; Sulem, P ; Theriault, S ; Thorsteinsdottir, U ; Trompet, S ; Varga, TV ; Edwards, DRV ; Veronesi, G ; Weiss, S ; Willems, SM ; Yao, J ; Young, R ; Yu, B ; Zhang, W ; Zhao, J-H ; Zhao, W ; Zhao, W ; Evangelou, E ; Aeschbacher, S ; Asllanaj, E ; Blankenberg, S ; Bonnycastle, LL ; Bork-Jensen, J ; Brandslund, I ; Braund, PS ; Burgess, S ; Cho, K ; Christensen, C ; Connell, J ; de Mutsert, R ; Dominiczak, AF ; Dorr, M ; Eiriksdottir, G ; Farmaki, A-E ; Gaziano, JM ; Grarup, N ; Grove, ML ; Hallmans, G ; Hansen, T ; Have, CT ; Heiss, G ; Jorgensen, ME ; Jousilahti, P ; Kajantie, E ; Kamat, M ; Karajamaki, A ; Karpe, F ; Koistinen, HA ; Kovesdy, CP ; Kuulasmaa, K ; Laatikainen, T ; Lannfelt, L ; Lee, I-T ; Lee, W-J ; Linneberg, A ; Martin, LW ; Moitry, M ; Nadkarni, G ; Neville, MJ ; Palmer, CNA ; Papanicolaou, GJ ; Pedersen, O ; Peters, J ; Poulter, N ; Rasheed, A ; Rasmussen, KL ; Rayner, NW ; Magi, R ; Renstrom, F ; Rettig, R ; Rossouw, J ; Schreiner, PJ ; Sever, PS ; Sigurdsson, EL ; Skaaby, T ; Sun, Y ; Sundstrom, J ; Thorgeirsson, G ; Esko, T ; Trabetti, E ; Tsao, PS ; Tuomi, T ; Turner, ST ; Tzoulaki, I ; Vaartjes, I ; Vergnaud, A-C ; Willer, CJ ; Wilson, PWF ; Witte, DR ; Yonova-Doing, E ; Zhang, H ; Aliya, N ; Almgren, P ; Amouyel, P ; Asselbergs, FW ; Barnes, MR ; Blakemore, A ; Boehnke, M ; Bots, ML ; Bottinger, EP ; Buring, JE ; Chambers, JC ; Chen, Y-DI ; Chowdhury, R ; Conen, D ; Correa, A ; Smith, GD ; de Boer, RA ; Deary, IJ ; Dedoussis, G ; Deloukas, P ; Di Angelantonio, E ; Elliott, P ; Felix, SB ; Ferrieres, J ; Ford, I ; Fornage, M ; Franks, PW ; Franks, S ; Frossard, P ; Gambaro, G ; Gaunt, TR ; Groop, L ; Gudnason, V ; Harris, TB ; Hayward, C ; Hennig, BJ ; Herzig, K-H ; Ingelsson, E ; Tuomilehto, J ; Jarvelin, M-R ; Jukema, JW ; Kardia, SLR ; Kee, F ; Kooner, JS ; Kooperberg, C ; Launer, LJ ; Lind, L ; Loos, RJF ; Majumder, AAS ; Laakso, M ; McCarthy, M ; Melander, O ; Mohlke, KL ; Murray, AD ; Nordestgaard, BG ; Orho-Melander, M ; Packard, CJ ; Padmanabhan, S ; Palmas, W ; Polasek, O ; Porteous, DJ ; Prentice, AM ; Province, MA ; Relton, CL ; Rice, K ; Ridker, PM ; Rolandsson, O ; Rosendaal, FR ; Rotter, J ; Rudan, I ; Salomaa, V ; Samani, NJ ; Sattar, N ; Sheu, WH-H ; Smith, BH ; Soranzo, N ; Spector, TD ; Starr, JM ; Sebert, S ; Taylor, KD ; Lakka, TA ; Timpson, NJ ; Tobin, MD ; van der Harst, P ; van der Meer, P ; Ramachandran, VS ; Verweij, N ; Virtamo, J ; Volker, U ; Weir, DR ; Zeggini, E ; Charchar, FJ ; Wareham, NJ ; Langenberg, C ; Tomaszewski, M ; Butterworth, AS ; Caulfield, MJ ; Danesh, J ; Edwards, TL ; Holm, H ; Hung, AM ; Lindgren, CM ; Liu, C ; Manning, AK ; Morris, AP ; Morrison, AC ; O'Donnell, CJ ; Psaty, BM ; Saleheen, D ; Stefansson, K ; Boerwinkle, E ; Chasman, D ; Levy, D ; Newton-Cheh, C ; Munroe, PB ; Howson, JMM (NATURE RESEARCH, 2020-12)
    Genetic studies of blood pressure (BP) to date have mainly analyzed common variants (minor allele frequency > 0.05). In a meta-analysis of up to ~1.3 million participants, we discovered 106 new BP-associated genomic regions and 87 rare (minor allele frequency ≤ 0.01) variant BP associations (P < 5 × 10-8), of which 32 were in new BP-associated loci and 55 were independent BP-associated single-nucleotide variants within known BP-associated regions. Average effects of rare variants (44% coding) were ~8 times larger than common variant effects and indicate potential candidate causal genes at new and known loci (for example, GATA5 and PLCB3). BP-associated variants (including rare and common) were enriched in regions of active chromatin in fetal tissues, potentially linking fetal development with BP regulation in later life. Multivariable Mendelian randomization suggested possible inverse effects of elevated systolic and diastolic BP on large artery stroke. Our study demonstrates the utility of rare-variant analyses for identifying candidate genes and the results highlight potential therapeutic targets.
  • Item
    Thumbnail Image
    Epigenome-wide association study of kidney function identifies trans-ethnic and ethnic-specific loci
    Breeze, CE ; Batorsky, A ; Lee, MK ; Szeto, MD ; Xu, X ; McCartney, DL ; Jiang, R ; Patki, A ; Kramer, HJ ; Eales, JM ; Raffield, L ; Lange, L ; Lange, E ; Durda, P ; Liu, Y ; Tracy, RP ; van den Berg, D ; Evans, KL ; Kraus, WE ; Shah, S ; Tiwari, HK ; Hou, L ; Whitsel, EA ; Jiang, X ; Charchar, FJ ; Baccarelli, AA ; Rich, SS ; Morris, AP ; Irvin, MR ; Arnett, DK ; Hauser, ER ; Rotter, JI ; Correa, A ; Hayward, C ; Horvath, S ; Marioni, RE ; Tomaszewski, M ; Beck, S ; Berndt, SI ; London, SJ ; Mychaleckyj, JC ; Franceschini, N (BMC, 2021-04-30)
    BACKGROUND: DNA methylation (DNAm) is associated with gene regulation and estimated glomerular filtration rate (eGFR), a measure of kidney function. Decreased eGFR is more common among US Hispanics and African Americans. The causes for this are poorly understood. We aimed to identify trans-ethnic and ethnic-specific differentially methylated positions (DMPs) associated with eGFR using an agnostic, genome-wide approach. METHODS: The study included up to 5428 participants from multi-ethnic studies for discovery and 8109 participants for replication. We tested the associations between whole blood DNAm and eGFR using beta values from Illumina 450K or EPIC arrays. Ethnicity-stratified analyses were performed using linear mixed models adjusting for age, sex, smoking, and study-specific and technical variables. Summary results were meta-analyzed within and across ethnicities. Findings were assessed using integrative epigenomics methods and pathway analyses. RESULTS: We identified 93 DMPs associated with eGFR at an FDR of 0.05 and replicated 13 and 1 DMPs across independent samples in trans-ethnic and African American meta-analyses, respectively. The study also validated 6 previously published DMPs. Identified DMPs showed significant overlap enrichment with DNase I hypersensitive sites in kidney tissue, sites associated with the expression of proximal genes, and transcription factor motifs and pathways associated with kidney tissue and kidney development. CONCLUSIONS: We uncovered trans-ethnic and ethnic-specific DMPs associated with eGFR, including DMPs enriched in regulatory elements in kidney tissue and pathways related to kidney development. These findings shed light on epigenetic mechanisms associated with kidney function, bridging the gap between population-specific eGFR-associated DNAm and tissue-specific regulatory context.
  • Item
    No Preview Available
    2020 International Society of Hypertension global hypertension practice guidelines
    Unger, T ; Borghi, C ; Charchar, F ; Khan, NA ; Poulter, NR ; Prabhakaran, D ; Ramirez, A ; Schlaich, M ; Stergiou, GS ; Tomaszewski, M ; Wainford, RD ; Williams, B ; Schutte, AE (LIPPINCOTT WILLIAMS & WILKINS, 2020-06)
    Document reviewers: Hind Beheiry (Sudan), Irina Chazova (Russia), Albertino Damasceno (Mozambique), Anna Dominiczak (UK), Anastase Dzudie (Cameroon), Stephen Harrap (Australia), Hiroshi Itoh (Japan), Tazeen Jafar (Singapore), Marc Jaffe (USA), Patricio Jaramillo-Lopez (Colombia), Kazuomi Kario (Japan), Giuseppe Mancia (Italy), Ana Mocumbi (Mozambique), Sanjeevi N.Narasingan (India), Elijah Ogola (Kenya), Srinath Reddy (India), Ernesto Schiffrin (Canada), Ann Soenarta (Indonesia), Rhian Touyz (UK), Yudah Turana (Indonesia), Michael Weber (USA), Paul Whelton (USA), Xin Hua Zhang, (Australia), Yuqing Zhang (China).